Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Australia and New Zealand MammoSite distributor announced
January 6th, 2005
Proxima Therapeutics announced that Nucletron will be the exclusive distributor of the MammoSite Radiation Therapy System in Australia and New Zealand. MammoSite was developed by Proxima and cleared by the U.S. Food and Drug Administration (FDA) in May 2002 and received Australian Registration in June 2003. With this partnership, a 5-day treatment regimen of partial breast irradiation with MammoSite will now be available to more than 11,000 women diagnosed with breast cancer each year in Australia and New Zealand. "The simplicity of the MammoSite therapy coupled with the short treatment time should be especially attractive to patients and physicians,...
Source: Women's Health Weekly (2005-01-06)
|
